Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology

The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk R...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) Jg. 135; H. 13; S. e793
Hauptverfasser:	Lloyd-Jones, Donald M, Huffman, Mark D, Karmali, Kunal N, Sanghavi, Darshak M, Wright, Janet S, Pelser, Colleen, Gulati, Martha, Masoudi, Frederick A, Goff, Jr, David C
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 28.03.2017
Schlagworte:	American Heart Association Cardiovascular Diseases - prevention & control Longitudinal Studies Medicare Risk Factors United States myocardial infarction mortality cardiovascular diseases morbidity stroke prevention AHA Scientific Statements population
ISSN:	1524-4539, 1524-4539
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk Reduction Model was developed by Million Hearts and the Center for Medicare & Medicaid Services as a strategy to assess a value-based payment approach toward reduction in 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smoking cessation). The purpose of this special report is to describe the development and intended use of the Million Hearts Longitudinal ASCVD Risk Assessment Tool. The Million Hearts Tool reinforces and builds on the "2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk" by allowing clinicians to estimate baseline and updated 10-year ASCVD risk estimates for primary prevention patients adhering to the appropriate ABCS over time, alone or in combination. The tool provides updated risk estimates based on evidence from high-quality systematic reviews and meta-analyses of the ABCS therapies. This novel approach to personalized estimation of benefits from risk-reducing therapies in primary prevention may help target therapies to those in whom they will provide the greatest benefit, and serves as the basis for a Center for Medicare & Medicaid Services program designed to evaluate the Million Hearts Cardiovascular Risk Reduction Model.
AbstractList	The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk Reduction Model was developed by Million Hearts and the Center for Medicare & Medicaid Services as a strategy to assess a value-based payment approach toward reduction in 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smoking cessation). The purpose of this special report is to describe the development and intended use of the Million Hearts Longitudinal ASCVD Risk Assessment Tool. The Million Hearts Tool reinforces and builds on the "2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk" by allowing clinicians to estimate baseline and updated 10-year ASCVD risk estimates for primary prevention patients adhering to the appropriate ABCS over time, alone or in combination. The tool provides updated risk estimates based on evidence from high-quality systematic reviews and meta-analyses of the ABCS therapies. This novel approach to personalized estimation of benefits from risk-reducing therapies in primary prevention may help target therapies to those in whom they will provide the greatest benefit, and serves as the basis for a Center for Medicare & Medicaid Services program designed to evaluate the Million Hearts Cardiovascular Risk Reduction Model. The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk Reduction Model was developed by Million Hearts and the Center for Medicare & Medicaid Services as a strategy to assess a value-based payment approach toward reduction in 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smoking cessation). The purpose of this special report is to describe the development and intended use of the Million Hearts Longitudinal ASCVD Risk Assessment Tool. The Million Hearts Tool reinforces and builds on the "2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk" by allowing clinicians to estimate baseline and updated 10-year ASCVD risk estimates for primary prevention patients adhering to the appropriate ABCS over time, alone or in combination. The tool provides updated risk estimates based on evidence from high-quality systematic reviews and meta-analyses of the ABCS therapies. This novel approach to personalized estimation of benefits from risk-reducing therapies in primary prevention may help target therapies to those in whom they will provide the greatest benefit, and serves as the basis for a Center for Medicare & Medicaid Services program designed to evaluate the Million Hearts Cardiovascular Risk Reduction Model.The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and healthcare strategies by 2017. The American Heart Association and American College of Cardiology support the program. The Cardiovascular Risk Reduction Model was developed by Million Hearts and the Center for Medicare & Medicaid Services as a strategy to assess a value-based payment approach toward reduction in 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smoking cessation). The purpose of this special report is to describe the development and intended use of the Million Hearts Longitudinal ASCVD Risk Assessment Tool. The Million Hearts Tool reinforces and builds on the "2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk" by allowing clinicians to estimate baseline and updated 10-year ASCVD risk estimates for primary prevention patients adhering to the appropriate ABCS over time, alone or in combination. The tool provides updated risk estimates based on evidence from high-quality systematic reviews and meta-analyses of the ABCS therapies. This novel approach to personalized estimation of benefits from risk-reducing therapies in primary prevention may help target therapies to those in whom they will provide the greatest benefit, and serves as the basis for a Center for Medicare & Medicaid Services program designed to evaluate the Million Hearts Cardiovascular Risk Reduction Model.
Author	Lloyd-Jones, Donald M Huffman, Mark D Wright, Janet S Pelser, Colleen Gulati, Martha Masoudi, Frederick A Goff, Jr, David C Karmali, Kunal N Sanghavi, Darshak M
Author_xml	– sequence: 1 givenname: Donald M surname: Lloyd-Jones fullname: Lloyd-Jones, Donald M – sequence: 2 givenname: Mark D surname: Huffman fullname: Huffman, Mark D – sequence: 3 givenname: Kunal N surname: Karmali fullname: Karmali, Kunal N – sequence: 4 givenname: Darshak M surname: Sanghavi fullname: Sanghavi, Darshak M – sequence: 5 givenname: Janet S surname: Wright fullname: Wright, Janet S – sequence: 6 givenname: Colleen surname: Pelser fullname: Pelser, Colleen – sequence: 7 givenname: Martha surname: Gulati fullname: Gulati, Martha – sequence: 8 givenname: Frederick A surname: Masoudi fullname: Masoudi, Frederick A – sequence: 9 givenname: David C surname: Goff, Jr fullname: Goff, Jr, David C
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27815375$$D View this record in MEDLINE/PubMed
BookMark	eNpVkUFP3DAQhU0FKrD0H1TVHHtZGseJnXALKRSkRUWw5bpy4snWrWOndrIS_75O2VZ0LjOS33zvWXNKDq2zSMh7mpxTyumn-vbhPHldGRdvyAnN02yZ5aw8fDUfk9MQfkQNZyJ_S45TUdA8jicH5CqMupejtltYObvV46S0lQYedPgZQFoFl2ix02OAa-96qKVX2u1kaCcjPdx73KEd9Q5h_R29HDQGqPpIgjtUupUe4T7ioyZczBK408ZoZ-EGpY_Q_0yrx_rp8x9rqELAEPq4B2vnzAVU8Dhgq-doODg_vsQZI7Hq0UenPXLedFE3ziZz_n_PtTMGtwiu2__CuO3zGTnqpAn4bt8X5Nv11bq-Wa6-frmtq9WyzVMmlmnDStaUTcfalivJG5XkKClXjWpFV_CUcsllkUtGu5SVWcFk1mQiUY0ok6wQ6YJ8fOEO3v2aMIybXocWjZEW3RQ2tGBcMF5E1IJ82Eunpke1GXy8kH_e_L1a-hvd6KAn
CitedBy_id	crossref_primary_10_1097_ICO_0000000000003129 crossref_primary_10_1111_ddg_15136_g crossref_primary_10_1016_j_annepidem_2023_09_010 crossref_primary_10_1093_eurheartj_ehx386 crossref_primary_10_1097_QAI_0000000000002286 crossref_primary_10_1016_S0140_6736_17_30553_6 crossref_primary_10_1161_HYPERTENSIONAHA_122_20678 crossref_primary_10_1186_s13063_020_05016_4 crossref_primary_10_3389_fpubh_2022_1006220 crossref_primary_10_1039_D3FO00019B crossref_primary_10_1093_eurheartj_ehae002 crossref_primary_10_1093_eurheartj_ehy839 crossref_primary_10_1093_milmed_usaf314 crossref_primary_10_1016_j_resuscitation_2021_09_021 crossref_primary_10_1111_ddg_15136 crossref_primary_10_7326_AITC202112210 crossref_primary_10_1001_jamanetworkopen_2024_42639 crossref_primary_10_1016_j_atherosclerosis_2018_01_033 crossref_primary_10_29254_2077_4214_2023_4_171_195_199 crossref_primary_10_1016_j_atherosclerosis_2018_09_015 crossref_primary_10_1016_j_jns_2024_122997 crossref_primary_10_1136_bmjopen_2020_043450 crossref_primary_10_1016_j_amjcard_2020_07_046 crossref_primary_10_1016_j_urology_2025_04_056 crossref_primary_10_1161_HYPERTENSIONAHA_120_15650 crossref_primary_10_1007_s11886_023_01982_8 crossref_primary_10_1186_s12872_021_02289_8 crossref_primary_10_1002_acr_25292 crossref_primary_10_1097_MNH_0000000000000672 crossref_primary_10_1093_jamia_ocy151 crossref_primary_10_1016_j_ajpc_2023_100612 crossref_primary_10_1136_bmjopen_2018_022755 crossref_primary_10_1001_jama_2024_12537 crossref_primary_10_1016_j_pcad_2020_02_003 crossref_primary_10_1111_jch_14336 crossref_primary_10_1016_S2468_2667_21_00230_9 crossref_primary_10_1161_CIRCULATIONAHA_121_054967 crossref_primary_10_1016_j_amjms_2025_07_004 crossref_primary_10_1161_STROKEAHA_119_027160 crossref_primary_10_1016_j_cjca_2024_06_001 crossref_primary_10_1161_CIR_0000000000001141 crossref_primary_10_1093_ije_dyab087 crossref_primary_10_1097_HCO_0000000000000528 crossref_primary_10_1215_00703370_11790645 crossref_primary_10_1136_fmch_2020_000780 crossref_primary_10_2215_CJN_15751020 crossref_primary_10_1093_neuros_nyy469 crossref_primary_10_1016_j_arcmed_2019_05_003 crossref_primary_10_1093_ndt_gfae268 crossref_primary_10_1161_JAHA_122_028527 crossref_primary_10_1016_j_amjcard_2021_12_030 crossref_primary_10_1016_j_amjcard_2025_04_013 crossref_primary_10_1161_CIRCULATIONAHA_120_052737 crossref_primary_10_1161_STROKEAHA_121_036400 crossref_primary_10_1161_JAHA_120_019695 crossref_primary_10_1001_jamanetworkopen_2021_12210 crossref_primary_10_1161_HYPERTENSIONAHA_117_09612 crossref_primary_10_1161_CIR_0000000000001026 crossref_primary_10_1186_s12911_023_02179_3 crossref_primary_10_1016_S0140_6736_25_01393_5 crossref_primary_10_1161_CIR_0000000000001191 crossref_primary_10_1016_S0140_6736_20_30613_9 crossref_primary_10_1016_j_suc_2020_12_012 crossref_primary_10_2147_NSS_S467516 crossref_primary_10_1001_jama_2019_10298 crossref_primary_10_1097_MD_0000000000029609
ContentType	Journal Article
Copyright	2016 by the American Heart Association, Inc., and the American College of Cardiology Foundation.
Copyright_xml	– notice: 2016 by the American Heart Association, Inc., and the American College of Cardiology Foundation.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1161/CIR.0000000000000467
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology
EISSN	1524-4539
ExternalDocumentID	27815375
Genre	Journal Article Review
GrantInformation_xml	– fundername: Intramural CDC HHS grantid: CC999999
GroupedDBID	--- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEBDS AEETU AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DU5 E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 7X8 ABUFD ACBKD ADKSD ADSXY
ID	FETCH-LOGICAL-c5237-2b393b9bf3cc6da6bd05ea16dbdc7f86216a6a85a31f239483a4b470db7904872
IEDL.DBID	7X8
ISICitedReferencesCount	61
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000397387200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1524-4539
IngestDate	Sun Nov 09 13:39:39 EST 2025 Mon Jul 21 06:01:40 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	13
Keywords	myocardial infarction mortality cardiovascular diseases morbidity stroke prevention AHA Scientific Statements population
Language	English
License	2016 by the American Heart Association, Inc., and the American College of Cardiology Foundation.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5237-2b393b9bf3cc6da6bd05ea16dbdc7f86216a6a85a31f239483a4b470db7904872
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
OpenAccessLink	https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000467
PMID	27815375
PQID	1836736886
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1836736886 pubmed_primary_27815375
PublicationCentury	2000
PublicationDate	2017-March-28
PublicationDateYYYYMMDD	2017-03-28
PublicationDate_xml	– month: 03 year: 2017 text: 2017-March-28 day: 28
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Circulation (New York, N.Y.)
PublicationTitleAlternate	Circulation
PublicationYear	2017
References	28348099 - Circulation. 2017 Mar 28;135(13):e824-e825. doi: 10.1161/CIR.0000000000000492.
References_xml	– reference: 28348099 - Circulation. 2017 Mar 28;135(13):e824-e825. doi: 10.1161/CIR.0000000000000492.
SSID	ssj0006375
Score	2.4661963
SecondaryResourceType	review_article
Snippet	The Million Hearts Initiative has a goal of preventing 1 million heart attacks and strokes-the leading causes of mortality-through several public health and...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	e793
SubjectTerms	American Heart Association Cardiovascular Diseases - prevention & control Longitudinal Studies Medicare Risk Factors United States
Title	Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology
URI	https://www.ncbi.nlm.nih.gov/pubmed/27815375 https://www.proquest.com/docview/1836736886
Volume	135
WOSCitedRecordID	wos000397387200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFDZLUcWFpQuUTQ8JcbM6k8WOe0Fh6KhI7WjUDmhuI69oBE2GSVuJf8_zkpZKHJDIIZckjhM_v9X-PkLe6ZK5wmWCWqcULSzGrNIIRx3aOh_BDpgKkPnHfDKp5nMxTQm3Li2r7HViUNSm1T5Hvo-i55cgVRX7sPpJPWuUr64mCo17ZCNHV8bLOZ_foIWzPADtookqaFHmIm2dQydnf_T5NEIX9kdimv-7kxmMzfjx_3bzCXmU3Eyoo1w8JXdts0W26wZD7PNf8B7Cws-QUd8imyepvr59hxzijPc-bPMNjltPZXRpPG0WnC677x3IxsBHVI5uedHBeN2ew-jWclboAaGuLMzCxi6Mw6H2fEYQK0JrC9OI5Nod-FvA70VE0YAjnHHY6K2X1mejr5_Cq6G-BhCFWdv-OIAazlbWp_shhhCxO-jNQl-Dik3CH_IX-n99OaVMoHXpK_zf2CFfxoez0RFNHBFUYwjNaaZw2JVQLteaGcmUGZRWDplRRnOH4dqQSSarUuZD51ngq1wWquADo7hA5cWzXXK_aRv7nECm0YxrK1GN2YJpJ5wwzhWVVtoIqfI98rYf8gXOQV9YkY1tL7vFzaDvkWdRbharCBayyHiFRoWXL_7h6ZfkYea9hkFOs-oV2XCogexr8kBfXSy79Zsg3HieTE9-A3p2CDg
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimating+Longitudinal+Risks+and+Benefits+From+Cardiovascular+Preventive+Therapies+Among+Medicare+Patients%3A+The+Million+Hearts+Longitudinal+ASCVD+Risk+Assessment+Tool%3A+A+Special+Report+From+the+American+Heart+Association+and+American+College+of+Cardiology&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Lloyd-Jones%2C+Donald+M&rft.au=Huffman%2C+Mark+D&rft.au=Karmali%2C+Kunal+N&rft.au=Sanghavi%2C+Darshak+M&rft.date=2017-03-28&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=135&rft.issue=13&rft.spage=e793&rft_id=info:doi/10.1161%2FCIR.0000000000000467&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon